LOPATIN, MARGARITA,TSIATIS, ATHANASIOS,SILK, CHRISTOPHER N.,MILLER, DAVID P.,CRAGER, MICHAEL,FEBBO, PHILLIP,KNEZEVIC, DEJAN
申请号：
CA3057440
公开号：
CA3057440A1
申请日:
2018.05.17
申请国别(地区):
CA
年份:
2018
代理人:
摘要：
The present disclosure relates to methods of monitoring bladder cancer patients and analyzing patient samples for presence of methylated DNA and optionally particular gene mutations. In some embodiments, analysis results are correlated with clinical outcome measures such as risk of bladder cancer recurrence.
